[ad_1]

This week, recent studies include Mandimycin for resistant fungal infections, fluctuating hospital AMR rates, a 6-month HIV treatment, global challenges in hepatitis testing, and the start of a Lassa fever vaccine trial.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *